Clinical Trial Update: A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow [NA]

View source ↗

Summary

A completed pilot clinical trial evaluating Belotero Balance injection for volume augmentation in the infraorbital hollow area with posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infraorbital Hollow Volume Loss
• Periorbital Aging

Drugs mentioned

• Belotero Balance (Hyaluronic acid dermal filler)

Snippet

Sponsor: Merz North America, Inc. | Conditions: Correction of Volume Loss in the Infraorbital Hollow Area | NA | Status: COMPLETED | Results posted: 2022-09-02